 | • レポートコード：MRC2-11QY04381 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は進行型再発性多発性硬化症治療のグローバル市場について調査・分析したレポートです。種類別（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別進行型再発性多発性硬化症治療の競争状況、市場シェア ・世界の進行型再発性多発性硬化症治療市場：種類別市場規模 2015年-2020年（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他） ・世界の進行型再発性多発性硬化症治療市場：種類別市場規模予測 2021年-2026年（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他） ・世界の進行型再発性多発性硬化症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の進行型再発性多発性硬化症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の進行型再発性多発性硬化症治療市場分析：米国、カナダ ・ヨーロッパの進行型再発性多発性硬化症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの進行型再発性多発性硬化症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の進行型再発性多発性硬化症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの進行型再発性多発性硬化症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cognosci Inc、Genzyme Corp、MedImmune LLC、VivaCell Biotechnology Espana SL ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market
The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Progressive Relapsing Multiple Sclerosis Treatment Scope and Market Size
Progressive Relapsing Multiple Sclerosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Relapsing Multiple Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Cognosci Inc
Genzyme Corp
MedImmune LLC
VivaCell Biotechnology Espana SL
…
Market segment by Type, the product can be split into
COG-133
GZ-402668
Inebilizumab
VCE-0032
Others
Market segment by Application, split into
Clinic
Hopital
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Progressive Relapsing Multiple Sclerosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 COG-133
1.4.3 GZ-402668
1.4.4 Inebilizumab
1.4.5 VCE-0032
1.4.6 Others
1.5 Market by Application
1.5.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hopital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Perspective (2015-2026)
2.2 Global Progressive Relapsing Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Progressive Relapsing Multiple Sclerosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Progressive Relapsing Multiple Sclerosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Progressive Relapsing Multiple Sclerosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Market Size
3.1.1 Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Progressive Relapsing Multiple Sclerosis Treatment Market Concentration Ratio
3.2.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Progressive Relapsing Multiple Sclerosis Treatment Revenue in 2019
3.3 Progressive Relapsing Multiple Sclerosis Treatment Key Players Head office and Area Served
3.4 Key Players Progressive Relapsing Multiple Sclerosis Treatment Product Solution and Service
3.5 Date of Enter into Progressive Relapsing Multiple Sclerosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Progressive Relapsing Multiple Sclerosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
5.2 Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
6.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in North America (2019-2020)
6.3 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
6.4 North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
7.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
7.4 Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
8.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in China (2019-2020)
8.3 China Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
8.4 China Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
9.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
9.4 Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
10.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
11.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in India (2019-2020)
11.3 India Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
11.4 India Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size (2015-2020)
12.2 Progressive Relapsing Multiple Sclerosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Cognosci Inc
13.1.1 Cognosci Inc Company Details
13.1.2 Cognosci Inc Business Overview
13.1.3 Cognosci Inc Progressive Relapsing Multiple Sclerosis Treatment Introduction
13.1.4 Cognosci Inc Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020))
13.1.5 Cognosci Inc Recent Development
13.2 Genzyme Corp
13.2.1 Genzyme Corp Company Details
13.2.2 Genzyme Corp Business Overview
13.2.3 Genzyme Corp Progressive Relapsing Multiple Sclerosis Treatment Introduction
13.2.4 Genzyme Corp Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020)
13.2.5 Genzyme Corp Recent Development
13.3 MedImmune LLC
13.3.1 MedImmune LLC Company Details
13.3.2 MedImmune LLC Business Overview
13.3.3 MedImmune LLC Progressive Relapsing Multiple Sclerosis Treatment Introduction
13.3.4 MedImmune LLC Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020)
13.3.5 MedImmune LLC Recent Development
13.4 VivaCell Biotechnology Espana SL
13.4.1 VivaCell Biotechnology Espana SL Company Details
13.4.2 VivaCell Biotechnology Espana SL Business Overview
13.4.3 VivaCell Biotechnology Espana SL Progressive Relapsing Multiple Sclerosis Treatment Introduction
13.4.4 VivaCell Biotechnology Espana SL Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020)
13.4.5 VivaCell Biotechnology Espana SL Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Progressive Relapsing Multiple Sclerosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Progressive Relapsing Multiple Sclerosis Treatment Revenue
Table 3. Ranking of Global Top Progressive Relapsing Multiple Sclerosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of COG-133
Table 6. Key Players of GZ-402668
Table 7. Key Players of Inebilizumab
Table 8. Key Players of VCE-0032
Table 9. Key Players of Others
Table 10. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2015-2020)
Table 14. Global Progressive Relapsing Multiple Sclerosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Progressive Relapsing Multiple Sclerosis Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Progressive Relapsing Multiple Sclerosis Treatment Players
Table 21. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players (2015-2020)
Table 23. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2019)
Table 24. Global Progressive Relapsing Multiple Sclerosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Progressive Relapsing Multiple Sclerosis Treatment Product Solution and Service
Table 27. Date of Enter into Progressive Relapsing Multiple Sclerosis Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Share by Type (2015-2020)
Table 31. Global Progressive Relapsing Multiple Sclerosis Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Share by Application (2015-2020)
Table 33. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 37. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 39. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 43. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 45. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 49. China Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 51. China Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 55. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 57. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 61. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 67. India Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 69. India Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Progressive Relapsing Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Progressive Relapsing Multiple Sclerosis Treatment Market Share (2019-2020)
Table 73. Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 77. Cognosci Inc Company Details
Table 78. Cognosci Inc Business Overview
Table 79. Cognosci Inc Product
Table 80. Cognosci Inc Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 81. Cognosci Inc Recent Development
Table 82. Genzyme Corp Company Details
Table 83. Genzyme Corp Business Overview
Table 84. Genzyme Corp Product
Table 85. Genzyme Corp Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 86. Genzyme Corp Recent Development
Table 87. MedImmune LLC Company Details
Table 88. MedImmune LLC Business Overview
Table 89. MedImmune LLC Product
Table 90. MedImmune LLC Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 91. MedImmune LLC Recent Development
Table 92. VivaCell Biotechnology Espana SL Company Details
Table 93. VivaCell Biotechnology Espana SL Business Overview
Table 94. VivaCell Biotechnology Espana SL Product
Table 95. VivaCell Biotechnology Espana SL Revenue in Progressive Relapsing Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 96. VivaCell Biotechnology Espana SL Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. COG-133 Features
Figure 3. GZ-402668 Features
Figure 4. Inebilizumab Features
Figure 5. VCE-0032 Features
Figure 6. Others Features
Figure 7. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hopital Case Studies
Figure 10. Others Case Studies
Figure 11. Progressive Relapsing Multiple Sclerosis Treatment Report Years Considered
Figure 12. Global Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Players in 2019
Figure 17. Global Top Progressive Relapsing Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Relapsing Multiple Sclerosis Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Progressive Relapsing Multiple Sclerosis Treatment Revenue in 2019
Figure 19. North America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Progressive Relapsing Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
一次進行型多発性硬化症治療の世界市場（～2026年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Primary Progressi…- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 多発性硬化症治療の世界市場（～2026年） Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
- 二次性進行型多発性硬化症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Secondary Progressive Multiple Sclerosis Drug Market The global Secondary Progressive Multiple Sclerosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Secondary Progressive M…
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…